For more information or confidential assistance
se habla español

Katarina Siegfeld

Katarina Siegfeld is a writer, professor, translator, and editor. Her training in art history and sociology plays a significant role in her concern for the social context of drug safety and litigation.

Axiron Lawsuit Filed Over Heart Attack Death

An Axiron lawsuit has been filed over a heart attack death that plaintiffs contend was caused by testosterone replacement therapy. The complaint, filed on March 17 in the U.S. District Court for the Northern District of Illinois, Eastern Division, names Janice Ollenburger, individually and on behalf of Jerry Ollenburger, the... Read more »

Risperdal Lawsuit over Gynecomastia Filed in Louisiana

Another Risperdal lawsuit over gynecomastia has been filed, this time in Louisiana. Karon-Jahlil Williams v. Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development, L.L.C. (Case # 5:14-cv-03354) was filed on December 2, 2014 in the US. District Court for the Western District of Louisiana (Shreveport Division). The... Read more »

FDA Panel Backs New Testosterone Drug Safety Limits

Amid concerns over testosterone therapy side effects, an FDA panel has backed limitations on labeling for testosterone to exclude prescriptions for men who take the therapy only to counteract ordinary signs of aging rather than specific hormonal abnormalities. The panel also voted overwhelmingly to require clinical safety trials for some... Read more »

$9 Billion Punitive Actos Lawsuit Award Upheld

The judge in one of the early Actos bladder cancer trials has upheld a record-breaking $9 billion punitive damages award against Takeda Pharmaceuticals and Eli Lilly, who recently attempted to have the Actos lawsuit award thrown out. U.S. District Judge Rebecca Doherty ruled that the jurors who assigned the award... Read more »